Akslen LA - Search Results

1

Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.

Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, Eggen AE, McTiernan A, Aziz S, Wist EA, Stensvold A, Reitan JB, Akslen LA, Thune I. Lofterød T, et al. Among authors: akslen la. BMC Cancer. 2018 Jun 15;18(1):654. doi: 10.1186/s12885-018-4568-2. BMC Cancer. 2018. PMID: 29902993 Free PMC article.

2

Survival and prognostic factors in differentiated thyroid cancer--a multivariate analysis of 1,055 cases.

Thoresen SO, Akslen LA, Glattre E, Haldorsen T, Lund EV, Schoultz M. Thoresen SO, et al. Among authors: akslen la. Br J Cancer. 1989 Feb;59(2):231-5. doi: 10.1038/bjc.1989.47. Br J Cancer. 1989. PMID: 2930688 Free PMC article.

3

Prognostic impact of EGF-receptor in papillary thyroid carcinoma.

Akslen LA, Myking AO, Salvesen H, Varhaug JE. Akslen LA, et al. Br J Cancer. 1993 Oct;68(4):808-12. doi: 10.1038/bjc.1993.432. Br J Cancer. 1993. PMID: 8398712 Free PMC article.

4

Prognostic importance of histologic grading in papillary thyroid carcinoma.

Akslen LA. Akslen LA. Cancer. 1993 Nov 1;72(9):2680-5. doi: 10.1002/1097-0142(19931101)72:9<2680::aid-cncr2820720926>3.0.co;2-d. Cancer. 1993. PMID: 8402490

5

Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.

Akslen LA, Varhaug JE. Akslen LA, et al. Cancer. 1995 Nov 1;76(9):1643-54. doi: 10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820760922>3.0.co;2-#. Cancer. 1995. PMID: 8635070

6

Independent prognostic importance of vascular invasion in nodular melanomas.

Straume O, Akslen LA. Straume O, et al. Among authors: akslen la. Cancer. 1996 Sep 15;78(6):1211-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C. Cancer. 1996. PMID: 8826942

7

Poorer survival of nulliparous women with endometrial carcinoma.

Salvesen HB, Akslen LA, Albrektsen G, Iversen OE. Salvesen HB, et al. Among authors: akslen la. Cancer. 1998 Apr 1;82(7):1328-33. doi: 10.1002/(sici)1097-0142(19980401)82:7<1328::aid-cncr16>3.0.co;2-8. Cancer. 1998. PMID: 9529025

8

Prognostic impact of morphometric nuclear grade of endometrial carcinoma.

Salvesen HB, Iversen OE, Akslen LA. Salvesen HB, et al. Among authors: akslen la. Cancer. 1998 Sep 1;83(5):956-64. Cancer. 1998. PMID: 9731900

9

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Geisler S, Lønning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Børresen-Dale AL. Geisler S, et al. Among authors: akslen la. Cancer Res. 2001 Mar 15;61(6):2505-12. Cancer Res. 2001. PMID: 11289122 Clinical Trial.

10

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.

Straume O, Chappuis PO, Salvesen HB, Halvorsen OJ, Haukaas SA, Goffin JR, Bégin LR, Foulkes WD, Akslen LA. Straume O, et al. Among authors: akslen la. Cancer Res. 2002 Dec 1;62(23):6808-11. Cancer Res. 2002. PMID: 12460889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters